Epigenetic activation of VEGFA by SMARCD1 mediates tumor progression and bevacizumab resistance in clear cell renal cell carcinoma
Abstract Background Clear cell renal cell carcinoma (ccRCC) is an aggressive malignancy characterized by strong invasiveness and treatment resistance. Although SMARCD1 has been studied in several cancers, its function in ccRCC and its regulatory relationship with the key angiogenic factor VEGFA rema...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2026-03-01
|
| Colección: | BMC Cancer |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s12885-026-15791-z |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|